Not exactly a group that will draw a crowd. And that's Cooperstown's problem.
Debate over performance enhancing drugs haven't damaged the business of the game, but it did jeopardize the business of the small town that hosts its most hallowed halls.
Huge crowds at induction weekend is key to this business. Take, for example, in 2007 when Tony Gwynn and Cal Ripken Jr. were inducted. The record breaking attendance numbers made up eight percent of that year's total attendance.
But when the biggest names aren't part of things, it's obviously not positive. Especially when your Hall Of Fame is four hours away from Manhattan, Boston and Philadelphia. You have to be motivated to make that kind of trip.
And the numbers prove that people aren't as interested as they were before. The local paper, the Cooperstown Crier, reported recently that the Baseball Hall of Fame is on pace with last year's attendance. That's not good when last year was the first year since 1997 that the institution drew fewer than 300,000 fans (298,818).
At least publicly Hall of Fame officials aren't aware that performance enhancing drugs are slowly killing the institution they work for.
In 2008, when attendance dropped 14 percent from 2007, Hall of Fame officials explained the falloff by talking about Gwynn and Ripken's weekend. It was an anomaly against a great year before, they said. The problem, of course, is that weekends like that might never come again.
According to the Hall of Fame's Internal Revenue Service 990 form from 2008, the last year that it's publicly available, the Hall of Fame had $9.9 million in revenue, but that wasn't enough to cover expenses. The organization lost $2.4 million that year, according to the form, representing only the second time (2006 being the other) in nine years that the museum lost money.